Skip to content

Comparison of the Decannulation Protocol With Suctioning and Capping in Severe Acquired Brain Injury Patients

Tracheostomy Decannulation in Severe Acquired Brain Injury: a Decannulation Protocol With Suctioning or Capping?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04835272
Enrollment
104
Registered
2021-04-08
Start date
2021-11-01
Completion date
2023-10-30
Last updated
2021-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Brain Injury, Tracheostomy Decannulation

Keywords

Tracheostomy, Decannulation, without capping, Airway patency assessment

Brief summary

Single-center randomized trail focused on tracheostomized patients with severe acquired brain injury , comparing two different decannulation protocols: 1. an assessment of readiness for decannulation that was based on suctioning frequency 2. an assessment that was based on tracheostomy capping

Interventions

PROCEDUREthe Decannulation Protocol With Suctioning

In the intervention group, the decision to decannulate was based on suctioning frequency. Patients underwent decannulation when they had had no more than two aspirations every 8 hours during during a 24-hour period. Patients in this group did not undergo capping trials.

Sponsors

Fu Xing Hospital, Capital Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Within three months of onset * Age≥18 years old * GCS≥8 * Clinical stability( defined as the absence of fever, sepsis, or active infection and hemodynamic stability) * Without massive pooling or silent aspiration of saliva, more than one efficient swallow per minute, adequate cough reflex were tested by gently touching the aryepiglottic region with the tip of the endoscope. * Passing a tracheostomy-tube de-cuff test(de-cuff the tube for 3 days without pulmonary complications. * Without significant airway stenosis.

Exclusion criteria

* Patients with pending diagnostic or therapeutic procedures and were considered by the clinicians to be at risk for neurologic deterioration * Medical history of severe respiratory system or heart disease * Neuromuscular disease other than ICU-acquired weakness, or tracheostomy for airway control * Don't get informed consent from patient or guardian

Design outcomes

Primary

MeasureTime frameDescription
the time to decannulationFrom the date of randomization to decannulation, and the patients will be followed for the duration of hospital stay, an expected average of 3 monthsthe time from randomization to actual decannulation

Secondary

MeasureTime frameDescription
Rate of decannulation failurewithin 1 week after decannulationreintubation within 1 week after decannulation
high dependency unit length of stayFrom the date of high dependency unit admission to transferring to rehabilitation ward, and the patients will be followed for the duration of high dependency unit stay, an expected average of 2 monthsthe time from high dependency unit admission to rehabilitation ward
Rate of respiratory infectionsFrom the date of high dependency unit admission to hospital discharge, and the patients will be followed for the duration of hospital stay, an expected average of 3 monthspost decannulation respiratory infections rate in each study group
Glasgow Outcome Scale(GOS) six months after the acute brain injuryfollow-up six months after dischargeThe GOS is a brief descriptive outcome scale(from 0 point to 29 points, higher score means worse outcome). GOS six months after discharge to asess the prognosis of the patient
Functional Independence Measure(FIM) six months after the acute brain injuryfollow up six months after dischargeThe FIM is an 18-item ordinal scale, is viewed as most useful for assessment of progress during inpatient rehabilitation(from 18 points to 126 points, higher score means better outcome).

Countries

China

Contacts

Primary ContactLu Song
songlu@ccmu.edu.cn+86 15010852973

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026